CMG Pharma's Mezofy gets first U.S. FDA approval for changed form for Korea
Mezofy, an oral film-type medication for treating schizophrenia developed by CMG Pharmaceutical, received approval from the U.S. Food and Drug Administration, a first for a change to medication form for a Korean firm.